The National Institutes of Health failed to insure that all clinical trials funded by the agency and required to be reported in 2019 and 2020 met federal requirements, according to an inspector general report released Tuesday.
The Department of Health and Human Services Office of Inspector General reviewed a total of 72 such trials from that period and found results were never submitted in 25, late in 12 and on time in 35.
Read More